BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19533707)

  • 1. A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.
    Trost BM; Dong G
    Chemistry; 2009 Jul; 15(28):6910-9. PubMed ID: 19533707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.
    Trost BM; Dong G
    J Am Chem Soc; 2006 May; 128(18):6054-5. PubMed ID: 16669672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.
    Wehn PM; Du Bois J
    Angew Chem Int Ed Engl; 2009; 48(21):3802-5. PubMed ID: 19378315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric aziridination of cyclic enones using chiral diamine catalysts and its application to the total synthesis of (-)-agelastatin A.
    Menjo Y; Hamajima A; Sasaki N; Hamada Y
    Org Lett; 2011 Nov; 13(21):5744-7. PubMed ID: 21966984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short total synthesis of the marine sponge pyrrole-2-aminoimidazole alkaloid (±)-agelastatin A.
    Duspara PA; Batey RA
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10862-6. PubMed ID: 24038621
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkynyliodonium salts in organic synthesis. Development of a unified strategy for the syntheses of (-)-agelastatin A and (-)-agelastatin B.
    Feldman KS; Saunders JC; Wrobleski ML
    J Org Chem; 2002 Oct; 67(20):7096-109. PubMed ID: 12354005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of (-)-agelastatin A by [3.3] sigmatropic rearrangement of allyl cyanate.
    Ichikawa Y; Yamaoka T; Nakano K; Kotsuki H
    Org Lett; 2007 Aug; 9(16):2989-92. PubMed ID: 17602639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereocontrolled synthesis of vicinal diamines by organocatalytic asymmetric Mannich reaction of N-protected aminoacetaldehydes: formal synthesis of (-)-agelastatin A.
    Kano T; Sakamoto R; Akakura M; Maruoka K
    J Am Chem Soc; 2012 May; 134(17):7516-20. PubMed ID: 22486203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
    Domostoj MM; Irving E; Scheinmann F; Hale KJ
    Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
    Dickson DP; Wardrop DJ
    Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.
    Hale KJ; Domostoj MM; Tocher DA; Irving E; Scheinmann F
    Org Lett; 2003 Aug; 5(16):2927-30. PubMed ID: 12889910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palladium-catalyzed asymmetric construction of vicinal all-carbon quaternary stereocenters and its application to the synthesis of cyclotryptamine alkaloids.
    Trost BM; Osipov M
    Angew Chem Int Ed Engl; 2013 Aug; 52(35):9176-81. PubMed ID: 23824625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step total syntheses of canthin-6-one alkaloids: new one-pot sequential Pd-catalyzed Suzuki-Miyaura coupling and Cu-catalyzed amidation reaction.
    Gollner A; Koutentis PA
    Org Lett; 2010 Mar; 12(6):1352-5. PubMed ID: 20192213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.
    Yoshimitsu T; Ino T; Futamura N; Kamon T; Tanaka T
    Org Lett; 2009 Aug; 11(15):3402-5. PubMed ID: 19588910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of (-)-agelastatin A.
    Yoshimitsu T; Ino T; Tanaka T
    Org Lett; 2008 Dec; 10(23):5457-60. PubMed ID: 19006318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palladium asymmetric allylic alkylation of prochiral nucleophiles: horsfiline.
    Trost BM; Brennan MK
    Org Lett; 2006 May; 8(10):2027-30. PubMed ID: 16671773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Iridium-Catalyzed Asymmetric Allylic Substitution Reactions in Target-Oriented Synthesis.
    Qu J; Helmchen G
    Acc Chem Res; 2017 Oct; 50(10):2539-2555. PubMed ID: 28937739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.
    Antropow AH; Xu K; Buchsbaum RJ; Movassaghi M
    J Org Chem; 2017 Aug; 82(15):7720-7731. PubMed ID: 28696693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper(I)-catalyzed enantioselective incorporation of ketones to cyclic hemiaminals for the synthesis of versatile alkaloid precursors.
    Shi SL; Wei XF; Shimizu Y; Kanai M
    J Am Chem Soc; 2012 Oct; 134(41):17019-22. PubMed ID: 23039221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkynyliodonium salts in organic synthesis. Application to the total synthesis of (-)-agelastatin A and (-)-agelastatin B.
    Feldman KS; Saunders JC
    J Am Chem Soc; 2002 Aug; 124(31):9060-1. PubMed ID: 12149004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.